RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Start Date
7/30/2025
Completion Date
12/1/2026
Summary
The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to active-placebo.
Eligibility Criteria
Age Range: 18 years to 80 years
Interventions
RE104 for Injection
Conditions
Locations
UAB, Psychiatry and Behavioral Neurology
Birmingham, Alabama 35209
United States
University of Arizona
Tucson, Arizona 85724
United States
Kadima Neuropsychiatry Institute
San Diego, California 92037
United States
Providence Medical Foundation
Santa Rosa, California 95403
United States
University of Colorado
Aurora, Colorado 80045
United States
University of South Florida, Department of Psychiatry and Behavioral Neuroscience
Tampa, Florida 33613
United States
Emory University
Atlanta, Georgia 30329
United States
Hawaii Pacific Neuroscience
Honolulu, Hawaii 96817
United States
Rush University Medical Center
Chicago, Illinois 60612
United States
The University of Kansas Medical Center
Kansas City, Kansas 66160
United States
LSU Health Shreveport
Shreveport, Louisiana 71103
United States
Sunstone Therapies, PC
Rockville, Maryland 20850
United States
Sheppard Pratt
Towson, Maryland 21204
United States
Dana Farber Cancer Institute
Boston, Massachusetts 02215
United States
University of Michigan
Ann Arbor, Michigan 48109
United States
Henry Ford Health
Novi, Michigan 48377
United States
University of Nebraska Medical Center
Omaha, Nebraska 68198
United States
University of New Mexico, School of Medicine
Albuquerque, New Mexico 87131
United States
Roswell Park Center Institute
Buffalo, New York 14263
United States
NYU Langone Center for Psychedelic Medicine
New York, New York 10016
United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina 27514
United States
Cleveland Clinic
Cleveland, Ohio 44113
United States
The Ohio State University, Department of Psychiatry
Columbus, Ohio 43210
United States
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States
Alliance for Multispecialty Research Clinical
Knoxville, Tennessee 37920
United States
Dell Medical School, University of Texas at Austin
Austin, Texas 78712
United States
Cedar Clinical Research Inc.
Draper, Utah 84020
United States
UVA Center for Psychiatric Clinical Research
Charlottesville, Virginia 22903
United States
Seattle Neuropsychiatric Treatment Center
Seattle, Washington 98104
United States
University of Wisconsin at Madison
Madison, Wisconsin 53792
United States